Canadians could join clinical trials for new COVID-19 vaccine, says researcher “So the nexus idea is incredibly ambitious, but I think it’s exactly where we need to go to be able to solve what we call wicked problems.
Very complex, multifactorial problems,” said Gerry Wright scientific director at McMaster’s Institute for Infectious Disease Research.
The group includes some of the university’s top researchers who mobilized on more than 100 COVID-19 related research projects and were awarded more than $20 million by the three levels of government during the pandemic.Some of the experts include:Wright says the point of the nexus project is to have a strong list of colleagues to call in a global outbreak with quick turnaround times on.